Rayence Records Strong Q2 Performance... Rising Expectations for H2

[Asia Economy Reporter Hyunseok Yoo] Rayence is expected to record strong performance in the second half of the year following the second quarter.

According to the financial investment industry on the 16th, Rayence posted sales of 36.7 billion KRW and an operating profit of 7.1 billion KRW in the second quarter. This represents increases of 59.5% and 570.2%, respectively, compared to the same period last year.

The growth in sales was largely driven by the Dental division. The Dental division recorded sales of 17.2 billion KRW in the second quarter, a 406.1% increase compared to the same period last year. Additionally, the Industrial division's CMOS products, which are estimated to have high profitability, showed growth in operating profit.

Jung Hongsik, a researcher at Ebest Investment & Securities, said, "This is the highest quarterly performance," adding, "The Industrial division recorded 2.8 billion KRW, a 133.5% increase compared to the same period last year, while CMOS grew to 2.0 billion KRW, up 171.8% during the same period." He further noted, "The important point is that this is estimated to be driven by demand for X-ray Detectors used in electric vehicle battery inspections, indicating strong growth potential going forward."

Performance improvement is also expected to continue in the second half of the year. Eugene Investment & Securities forecasts that Rayence's sales and operating profit in the third quarter will reach 36.2 billion KRW and 6.7 billion KRW, respectively, representing increases of 55.9% and 2266.8% compared to the same period last year. Park Jongseon, a researcher at Eugene Investment & Securities, explained, "This is because the recovery of dental medical devices, the core business, has begun, and performance targeting China is gradually recovering."

This content was produced with the assistance of AI translation services.